Urinary Tract Infections Therapy Area Pipeline Report
- Published: March 2011
Infections Urinary Tract Infections
Infections Urinary Tract Infections
- Published: March 2008
- 82 pages
- Life Science Analytics
"Infections Urinary Tract Infections " contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each ’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a
READ MORE >
Urinary Tract Infections Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Top Companies in late stage Urinary Tract Infections Projects
--Osel Inc.
--Pfizer Inc
--Top Companies in early stage Urinary Tract Infections Projects
--Chaperone Technologies, Inc.
--ConjuGon Inc
--MiddleBrook Pharmaceuticals, Inc.
--Nymox Pharmaceutical Corporation
--Procter & Gamble Company
--TaiGen Biotechnology Co., Ltd.
Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | |
| Hard Copy | A printed copy of the report will be shipped to you. |
Note: Product cover images may vary from those shown
RELATED PRODUCTS
-
FROM
-
Respiratory Tract Infections Therapy Area Pipeline Report
- Published: March 2011
FROM -
Urinary Tract Infections - Pipeline Review, Q4 2010
- Published: December 2010
FROM -
Respiratory and Pulmonary System Respiratory Tract Infections
- Language: English
- Published: March 2008
FROM -
Urinary Tract Infections - Pipeline Review, H2 2012
- Language: English
- Published: August 2012
FROM -
TaiGen Biotechnology Co., Ltd. - Product Pipeline Review - 2012
- Language: English
- Published: October 2012
FROM -
Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential
- Language: English
- 145 Pages
- Published: May 2012
- Region: World
FROM -
Global Urinary Tract Infections Drug Pipeline Capsule - 2012 Update
- Language: English
- Published: September 2012
FROM -
Global Genitourinary Disorders Drug Pipeline Capsule – 2012
- Language: English
- 70 Pages
- Published: November 2012
- Region: World
FROM -
Global Urinary Tract Infections Pipeline Capsule - 2013
- Language: English
- 25 Pages
- Published: April 2013
- Region: World
FROM
